Scarica l'app Stockscreener
1.28
0.00%
0.00
Dopo l'orario di chiusura:
1.25
-0.03
-2.34%
Precedente Chiudi:
$1.28
Aprire:
$1.27
Volume 24 ore:
274.88K
Relative Volume:
0.27
Capitalizzazione di mercato:
$76.68M
Reddito:
$8.38M
Utile/perdita netta:
$-27.19M
Rapporto P/E:
-1.1743
EPS:
-1.09
Flusso di cassa netto:
$-13.59M
1 W Prestazione:
+7.56%
1M Prestazione:
+18.52%
6M Prestazione:
+28.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.24
$1.2851
Intervallo di 1 settimana:
$1.17
$1.35
Portata 52W:
$0.65
$1.75
Opus Genetics Inc Stock (IRD) Company Profile
Nome
Opus Genetics Inc
Settore
Industria
Telefono
248-681-9815
Indirizzo
8 DAVIS DRIVE, DURHAM
Confronta IRD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRD
Opus Genetics Inc
|
1.28 | 73.69M | 8.38M | -27.19M | -13.59M | -1.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Opus Genetics Inc Stock (IRD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-11 | Iniziato | Craig Hallum | Buy |
| 2024-11-13 | Ripresa | H.C. Wainwright | Buy |
Opus Genetics Inc Borsa (IRD) Ultime notizie
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Gene Therapy Leader Opus Genetics to Showcase IRD Pipeline at H.C. Wainwright Global Conference - Stock Titan
Opus Genetics Inc. stock volume spike explainedAnalyst Upgrade & Weekly High Conviction Ideas - Newser
Analyzing recovery setups for Opus Genetics Inc. investorsEarnings Risk Report & Reliable Volume Spike Alerts - Newser
Smart tools for monitoring Opus Genetics Inc.’s price actionPortfolio Performance Summary & Risk Controlled Swing Alerts - Newser
Using data tools to time your Opus Genetics Inc. exitShare Buyback & Community Consensus Trade Alerts - Newser
Using Bollinger Bands to evaluate Opus Genetics Inc.2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
What MACD and RSI say about Opus Genetics Inc.Gap Up & Low Risk Entry Point Guides - Newser
Regression analysis insights on Opus Genetics Inc. performanceWeekly Investment Recap & Smart Money Movement Tracker - Newser
Opus Genetics Inc. stock prediction for this weekJuly 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Statistical indicators supporting Opus Genetics Inc.’s strength2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
Visualizing Opus Genetics Inc. stock with heatmapsMarket Weekly Review & Weekly High Conviction Ideas - Newser
Will Opus Genetics Inc. continue its uptrendEarnings Growth Report & Safe Capital Growth Tips - Newser
Ranking Opus Genetics Inc. among high performing stocks via toolsJuly 2025 Market Mood & Weekly Breakout Stock Alerts - Newser
Opus Genetics Inc. stock trendline breakdownJuly 2025 News Drivers & Short-Term High Return Strategies - Newser
Is Opus Genetics Inc. impacted by rising ratesJuly 2025 Short Interest & Weekly High Return Stock Opportunities - khodrobank.com
Harvard Bioscience shares fall 3.03% intraday after Opus Genetics appoints new CFO. - AInvest
Opus Genetics' Strategic CFO Appointment and Its Implications for Biotech Capital Efficiency and Growth - AInvest
Opus Genetics Names Rob Gagnon as New CFO - AInvest
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer - GlobeNewswire
Biotech Veteran Who Raised $2B in Capital Joins Opus Genetics as CFO Ahead of Key Clinical Milestones - Stock Titan
Can Opus Genetics Inc. expand its profit margins2025 Market WrapUp & Community Consensus Picks - khodrobank.com
How sentiment analysis helps forecast Opus Genetics Inc.July 2025 Decliners & Weekly Market Pulse Updates - Newser
Comparing Opus Genetics Inc. in custom built stock radarsPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Is Opus Genetics Inc. stock heavily shorted2025 Investor Takeaways & Accurate Trade Setup Notifications - khodrobank.com
Earnings visualization tools for Opus Genetics Inc.Market Movement Recap & Technical Entry and Exit Tips - Newser
What does recent volatility data suggest for Opus Genetics Inc.Earnings Growth Summary & Weekly Hot Stock Watchlists - Newser
Custom watchlist performance reports with Opus Genetics Inc.Quarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Is Opus Genetics Inc. stock reversal real or fakeDollar Strength & Safe Capital Growth Trade Ideas - Newser
Opus Genetics Inc. stock outlook for YEAREarnings Beat & Precise Buy Zone Identification - Newser
Can Opus Genetics Inc. rally from current levelsQuarterly Trade Review & Real-Time Market Sentiment Reports - Newser
Is Opus Genetics Inc. trending in predictive chart models2025 Price Action Summary & Verified Technical Signals - Newser
What makes Opus Genetics Inc. stock price move sharplyQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
Trend Dashboard Flags Opus Genetics Inc. As Potential Swing Trade2025 Geopolitical Influence & Reliable Intraday Trade Plans - sundaytimes.kr
Is Opus Genetics Inc. affected by consumer sentimentMarket Performance Report & High Return Trade Guides - sundaytimes.kr
Opus Genetics Inc Azioni (IRD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opus Genetics Inc Azioni (IRD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| YERXA BENJAMIN R | President |
Nov 21 '24 |
Buy |
0.98 |
10,000 |
9,834 |
342,800 |
| Magrath George | Chief Executive Officer |
Nov 15 '24 |
Buy |
1.01 |
90,294 |
91,215 |
483,244 |
| Magrath George | Chief Executive Officer |
Nov 18 '24 |
Buy |
1.02 |
9,706 |
9,943 |
492,950 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):